VistaGen Therapeutics (VTGN) Revenue & Revenue Breakdown
VistaGen Therapeutics Revenue Highlights
Latest Revenue (Y)
$1.06M
Latest Revenue (Q)
$183.00K
Main Segment (Y)
License
Main Geography (Y)
License
VistaGen Therapeutics Revenue by Period
VistaGen Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $1.06M | -568.10% |
| 2023-03-31 | $-227.30K | -120.50% |
| 2022-03-31 | $1.11M | 1.78% |
| 2021-03-31 | $1.09M | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-03-31 | - | -100.00% |
| 2017-03-31 | $1.25M | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-03-31 | - | -100.00% |
| 2013-03-31 | $200.40K | -85.07% |
| 2012-03-31 | $1.34M | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2007-12-31 | - | - |
VistaGen Therapeutics generated $1.06M in revenue during NA 2024, up -568.10% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
VistaGen Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $183.00K | 117.86% |
| 2024-06-30 | $84.00K | -57.43% |
| 2024-03-31 | $197.30K | -52.04% |
| 2023-12-31 | $411.40K | 48.15% |
| 2023-09-30 | $277.70K | 56.36% |
| 2023-06-30 | $177.60K | 1.14% |
| 2023-03-31 | $175.60K | -2.23% |
| 2022-12-31 | $179.60K | -120.12% |
| 2022-09-30 | $-892.50K | -387.81% |
| 2022-06-30 | $310.10K | 697.17% |
| 2022-03-31 | $38.90K | -89.13% |
| 2021-12-31 | $357.90K | -0.03% |
| 2021-09-30 | $358.00K | 1.10% |
| 2021-06-30 | $354.10K | -19.87% |
| 2021-03-31 | $441.90K | 40.91% |
| 2020-12-31 | $313.60K | -6.11% |
| 2020-09-30 | $334.00K | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | -100.00% |
| 2017-03-31 | $1.25B | 99800.00% |
| 2016-12-31 | $1.25M | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | -100.00% |
| 2012-06-30 | $200.40K | -57.26% |
| 2012-03-31 | $468.93K | 19727.95% |
| 2011-12-31 | $2.37K | -99.25% |
| 2011-09-30 | $316.29K | -42.97% |
| 2011-06-30 | $554.62K | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | - |
VistaGen Therapeutics generated $183.00K in revenue during Q2 2025, up 117.86% compared to the previous quarter, and up 103.04% compared to the same period a year ago.
VistaGen Therapeutics Revenue Breakdown
VistaGen Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Mar 22 |
|---|---|
| License | $1.11M |
VistaGen Therapeutics's latest annual revenue breakdown by segment (product or service), as of Mar 22: License (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 23 | Mar 22 |
|---|---|---|
| License | $177.60K | $39.00K |
VistaGen Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 23: License (100.00%).
VistaGen Therapeutics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Mar 22 |
|---|---|
| License | $1.11M |
VistaGen Therapeutics's latest annual revenue breakdown by geography, as of Mar 22: License (100.00%).
Quarterly Revenue by Country
| Country | Mar 22 |
|---|---|
| License | $39.00K |
VistaGen Therapeutics's latest quarterly revenue breakdown by geography, as of Mar 22: License (100.00%).
VistaGen Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ACIU | AC Immune SA | $14.80M | - |
| KZR | Kezar Life Sciences | $7.00M | - |
| SYBX | Synlogic | $3.37M | - |
| XBIO | Xenetic Biosciences | $2.54M | $614.24K |
| VTGN | VistaGen Therapeutics | $1.06M | $183.00K |
| BPTH | Bio-Path | - | - |
| COCP | Cocrystal Pharma | - | - |
| CYTO | Altamira Therapeutics | - | $52.73K |
| REVB | Revelation Biosciences | - | - |
| ENTX | Entera Bio | - | $42.00K |
| TPST | Tempest Therapeutics | - | - |
| DRMA | Dermata Therapeutics | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |